Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

SANTA CLARA, Calif., October 21, 2021  Agilent Technologies Inc. (NYSE: A) today announced it has received CE-IVD mark approval for the PD-L1 IHC 28-8 pharmDx to guide options for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal cancers. Gastric (stomach) cancer is the fifth most common cancer and... Read more

Olympus Announces New Cloud Solution to Streamline Life Science Research

A central hub for research data enables greater productivity at universities and labs October 20, 2021 Olympus is proud to start offering the Olympus Life Science Solution Cloud (OLSC) in Japan to streamline life science research at universities and laboratories. The OLSC provides researchers with a central hub to store and access data—including images, notes... Read more

Waters and University of Delaware Announce Bioprocessing Innovation Partnership, Plan 2022 Opening of Immerse Delaware Lab

Partnership will focus on developing analytical solutions to better characterize bioprocesses towards improved quality, yields and efficiency News Summary: Waters and University of Delaware announce a multi-year collaboration to develop technology for analytical characterization of manufacturing processes for biologics and novel modalities. Waters’ staff and university researchers will co-locate at Immerse™ Delaware, an Innovation and... Read more

Unchained Labs blasts Big Kahuna and Junior into the future, launches LEA 10!

October 19, 2021 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, released its LEA 10 automation software today – making Big Kahuna and Junior even more ready to plow through scientific challenges and workflow bottlenecks. Big Kahuna and Junior are workhorses that labs rely... Read more

Walsh University and Shimadzu Scientific Instruments to Dedicate New Center for Analytical Excellence Laboratory for Advanced Chemical Analysis

Walsh University (North Canton, OH) and Shimadzu Scientific Instruments (SSI) will dedicate the Center for Analytical Excellence Laboratory, a collaborative project that includes the installation of nearly $1.2 million worth of new analytical equipment. This ongoing partnership was developed through the Shimadzu Partnership for Academics, Research and Quality of Life (SPARQ) program, which is designed... Read more

Eppendorf AG completes conversion to European public limited company

19.10.2021 Hamburg, October 2021 • Conversion to SE (“Societas Europaea”) completed • No impact on current business• Group headquarter remains in Hamburg, Germany The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021. The company will operate as Eppendorf SE... Read more

Clear Labs Automated NGS Technology Platform (Clear Safety™) Approved by USDA’s National Poultry Improvement Plan for Salmonella Detection

Leader in Next-Generation Sequencing Workflow Automation Gains Agency Accreditation for Animal Health Testing SAN CARLOS, CALIF. (PRWEB) OCTOBER 14, 2021 Today, Clear Labs, a leader in providing fully automated, next-generation sequencing (NGS) platforms for turnkey diagnostics, is announcing that Clear Safety Salmonella has been approved by the National Poultry Improvement Plan (NPIP) for interim use in the detection of... Read more

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer

SANTA CLARA, Calif., October 13, 2021  Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered.... Read more

Fluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis Software

Oct 12, 2021 Native Reading of Hyperion Imaging System Data Files on the Visiopharm Platform to Streamline Data Analysis for Researchers SOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a new co-marketing program to offer Visiopharm® image... Read more